Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib

AIM: To evaluate the value of systemic inflammation-based markers as prognostic factors for advanced pancreatic cancer (PC). METHODS: Data from 82 patients who underwent combination chemotherapy with gemcitabine and erlotinib for PC from 2011 to 2014 were collected retrospectively. Data that include...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastrointest Oncol
Main Authors: Lee, Jae Min, Lee, Hong Sik, Hyun, Jong Jin, Choi, Hyuk Soon, Kim, Eun Sun, Keum, Bora, Seo, Yeon Seok, Jeen, Yoon Tae, Chun, Hoon Jai, Um, Soon Ho, Kim, Chang Duck
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2016
Assuntos:
Retrospective Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4942744/
https://ncbi.nlm.nih.gov/pubmed/27559435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v8.i7.555
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados